Showing results (2851-2860 of 4,603) with videos related to

Sort By:
Pageof 461
Experimental Dermatology|December 5, 2008
Molecular diagnosis in dermatopathology: what makes sense, and what doesn'tMarkus Braun-Falco, Werner Schempp, Wolfgang Weyers
Experimental Dermatology|December 5, 2008
Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunitySandra Balkow, Karin Loser, Mathias Krummen, et al.
Experimental Dermatology|December 5, 2008
The human orthologue of murine Mpzl3 with predicted adhesive and immune functions is a potential candidate gene for immune-related hereditary hair lossPeter Racz, Matyas Mink, Anita Ordas, et al.
Experimental Dermatology|December 5, 2008
Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanismsQiaoli Li, Qiujie Jiang, Ellen Pfendner, et al.
Experimental Dermatology|June 27, 2009
Association of thymic stromal lymphopoietin gene -847C>T polymorphism in generalized vitiligoKyung Ah Cheong, Soo-Cheon Chae, Yong-Shin Kim, et al.
Experimental Dermatology|June 27, 2009
p63 directly induces expression of Alox12, a regulator of epidermal barrier formationSoeun Kim, Irene F Choi, Jessica R Quante, et al.
Experimental Dermatology|June 27, 2009
New developments in our understanding of acne pathogenesis and treatmentIchiro Kurokawa, F William Danby, Qiang Ju, et al.
Experimental Dermatology|June 30, 2009
Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathwaysSmita Agarwal, Chandrani Achari, D Praveen, et al.
Experimental Dermatology|June 30, 2009
Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathologyFranziska Buback, Andreas C Renkl, Guido Schulz, et al.
Experimental Dermatology|June 30, 2009
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERCFrancoise A Gourronc, mckaylee M Robertson, Annie K Herrig, et al.
Pageof 461